ResNovas Therapeutics
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$500,000
Company Overview
ResNovas Therapeutics is a drug discovery company developing targeted protein degradation therapies designed to enable treatment of disease at the molecular level.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
multi-pronged therapycombination therapyneurodegenerative diseaseALS treatmentALSpreclinical biotechdrug discoverytherapeutic platformtargeted protein degradationTPDmolecular gluepharma licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ResNovas Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ResNovas Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Pre Seed | Dec 31, 2025 | ||||
| Accelerator | Oct 9, 2025 | ||||
| Accelerator | Sep 30, 2025 | ||||
| Seed | Aug 15, 2024 |
ResNovas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Pre Seed |
| StartX | Accelerator |
| Dalena Capital | Seed |
| Astellas Venture Management | Seed |
| Ono Venture Investment, Inc. | Pre Seed |
| Mission BioCapital | Pre Seed, Seed |
| TIAP | Pre Seed |
ResNovas Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ResNovas Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersAlameda, California
Year Founded2025
Last FundingApr 28, 2026